Anavex Life Sciences Corp.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial…
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Anavex Life Sciences Corp. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAnavex Life Sciences Corp. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Anavex Life Sciences Corp..
If you want to see a demo, head over to the financial segments of AAPL